サンバイオの株価時系列
日付 | 始値 | 高値 | 安値 | 終値 | 前日比 | 騰落率 | 出来高 |
---|---|---|---|---|---|---|---|
2017/12/06 | 3,000 | 3,170 | 2,898 | 3,015 | +127 | +4.4% | 1,108,400 |
2017/12/05 | 3,015 | 3,040 | 2,873 | 2,888 | -167 | -5.5% | 875,500 |
2017/12/04 | 2,875 | 3,220 | 2,865 | 3,055 | +252 | +9% | 1,307,000 |
2017/12/01 | 2,810 | 2,853 | 2,768 | 2,803 | -3 | -0.1% | 357,100 |
2017/11/30 | 2,810 | 2,870 | 2,754 | 2,806 | +1 | ±0% | 824,200 |
2017/11/29 | 2,610 | 2,823 | 2,610 | 2,805 | +196 | +7.5% | 1,261,200 |
2017/11/28 | 2,578 | 2,648 | 2,512 | 2,609 | +25 | +1% | 356,500 |
2017/11/27 | 2,533 | 2,688 | 2,530 | 2,584 | +51 | +2% | 767,500 |
2017/11/24 | 2,782 | 2,812 | 2,503 | 2,533 | -232 | -8.4% | 1,368,800 |
2017/11/22 | 2,664 | 2,794 | 2,657 | 2,765 | +126 | +4.8% | 883,500 |
2017/11/21 | 2,511 | 2,646 | 2,485 | 2,639 | +106 | +4.2% | 948,800 |
2017/11/20 | 2,382 | 2,570 | 2,371 | 2,533 | +145 | +6.1% | 1,282,600 |
2017/11/17 | 2,241 | 2,419 | 2,220 | 2,388 | +177 | +8% | 1,197,000 |
2017/11/16 | 2,050 | 2,226 | 2,044 | 2,211 | +168 | +8.2% | 995,800 |
2017/11/15 | 2,084 | 2,129 | 2,022 | 2,043 | -24 | -1.2% | 416,500 |
2017/11/14 | 2,092 | 2,098 | 2,050 | 2,067 | -25 | -1.2% | 209,100 |
2017/11/13 | 2,084 | 2,123 | 2,070 | 2,092 | +9 | +0.4% | 194,900 |
2017/11/10 | 2,030 | 2,099 | 2,006 | 2,083 | +40 | +2% | 301,900 |
2017/11/09 | 2,140 | 2,140 | 2,009 | 2,043 | -97 | -4.5% | 511,700 |
2017/11/08 | 2,090 | 2,149 | 2,058 | 2,140 | +55 | +2.6% | 367,800 |
2017/11/07 | 2,117 | 2,205 | 1,988 | 2,085 | -20 | -1% | 790,500 |
2017/11/06 | 2,122 | 2,167 | 2,058 | 2,105 | -67 | -3.1% | 487,100 |
2017/11/02 | 2,261 | 2,263 | 2,073 | 2,172 | -74 | -3.3% | 715,600 |
2017/11/01 | 2,140 | 2,297 | 2,135 | 2,246 | +152 | +7.3% | 1,538,400 |
2017/10/31 | 2,100 | 2,137 | 2,062 | 2,094 | -26 | -1.2% | 525,800 |
2017/10/30 | 2,011 | 2,140 | 2,001 | 2,120 | +132 | +6.6% | 729,600 |
2017/10/27 | 1,982 | 2,020 | 1,981 | 1,988 | +4 | +0.2% | 306,900 |
2017/10/26 | 1,900 | 2,037 | 1,894 | 1,984 | +73 | +3.8% | 743,800 |
2017/10/25 | 1,950 | 1,995 | 1,903 | 1,911 | -45 | -2.3% | 434,600 |
2017/10/24 | 1,930 | 1,973 | 1,896 | 1,956 | -2 | -0.1% | 542,900 |
2017/10/23 | 1,820 | 1,978 | 1,813 | 1,958 | +150 | +8.3% | 586,000 |
2017/10/20 | 1,785 | 1,868 | 1,757 | 1,808 | -11 | -0.6% | 590,000 |
2017/10/19 | 1,888 | 1,897 | 1,794 | 1,819 | -68 | -3.6% | 628,300 |
2017/10/18 | 1,915 | 1,931 | 1,857 | 1,887 | -31 | -1.6% | 448,100 |
2017/10/17 | 2,070 | 2,124 | 1,807 | 1,918 | -160 | -7.7% | 1,647,600 |
2017/10/16 | 2,100 | 2,130 | 2,027 | 2,078 | -6 | -0.3% | 1,007,400 |
2017/10/13 | 1,920 | 2,088 | 1,891 | 2,084 | +174 | +9.1% | 1,369,000 |
2017/10/12 | 1,931 | 1,950 | 1,905 | 1,910 | -3 | -0.2% | 322,900 |
2017/10/11 | 1,917 | 1,967 | 1,889 | 1,913 | -10 | -0.5% | 695,300 |
2017/10/10 | 1,870 | 1,969 | 1,860 | 1,923 | +93 | +5.1% | 1,092,000 |
2017/10/06 | 1,730 | 1,959 | 1,726 | 1,830 | +97 | +5.6% | 1,851,100 |
2017/10/05 | 1,707 | 1,733 | 1,684 | 1,733 | +59 | +3.5% | 404,800 |
2017/10/04 | 1,710 | 1,739 | 1,667 | 1,674 | -15 | -0.9% | 507,500 |
2017/10/03 | 1,612 | 1,696 | 1,582 | 1,689 | +59 | +3.6% | 639,900 |
2017/10/02 | 1,675 | 1,683 | 1,612 | 1,630 | -43 | -2.6% | 428,500 |
2017/09/29 | 1,675 | 1,685 | 1,637 | 1,673 | +4 | +0.2% | 363,400 |
2017/09/28 | 1,594 | 1,680 | 1,593 | 1,669 | +91 | +5.8% | 815,600 |
2017/09/27 | 1,556 | 1,579 | 1,526 | 1,578 | +37 | +2.4% | 305,500 |
2017/09/26 | 1,504 | 1,545 | 1,453 | 1,541 | +21 | +1.4% | 312,400 |
2017/09/25 | 1,515 | 1,596 | 1,509 | 1,520 | +17 | +1.1% | 630,800 |
1701~
1750
件表示中 / 2354件
類似銘柄と比較する
現在ご覧いただいている「サンバイオ」と類似性の高い銘柄をピックアップ。投資家が注目しているデータで比較できるようになっています。銘柄選びの参考情報としてご活用ください。
銘柄名 | 最低購入代金 | 売上高 成長率 |
経常 増益率 |
配当 利回り |
PER | PBR | 直近のチャート | 特色 |
---|---|---|---|---|---|---|---|---|
サンバイオ | 96,500円 | - | - | 0.00% | - | 48.59倍 |
|
脳疾患向け再生細胞薬の開発・製造・販売目指すバイオベンチャー。米国で創業し日本に逆上陸 |
JCRファーマ | 72,400円 | -3.7% | -36.7% | 2.76% | 23.84倍 | 1.56倍 |
|
ヒト成長ホルモン製剤が主力、バイオ後続品も成長。希少疾病のバイオ新薬開発にも取り組む |
栄研化 | 209,200円 | +0.4% | -8.4% | 2.53% | 27.65倍 | 1.57倍 |
|
臨床検査薬大手。便潜血検査試薬(FIT)はシェア7割。尿検査(ウロ)、遺伝子検査も育成 |
あすかHD | 203,600円 | +0.3% | +2.7% | 2.46% | 11.55倍 | 0.90倍 |
|
武田と親密。婦人科領域に強い。先発品比率引き上げに注力。21年春にあすか製薬が持株会社化 |
タウンズ | 56,300円 | +4.6% | +6.1% | 4.97% | 9.46倍 | 4.17倍 |
|
院内で行う迅速抗原検査の体外診断薬専業大手。新型コロナ、インフルなど呼吸器感染症得意 |
市場注目の銘柄
チャート関連のコラム